// App-Quantinova.ai

: Modelling peripheral blood eosinophils to identify response to budesonide in COPD: a post-hoc analysis

Researchers

Presenter

  • Mona Bafadhel

Principal Investigators

  • Stefan Peterson

  • Miguel De Blas

  • Peter Calverley

  • Stephen Rennard

  • Kai Richter

  • Malin Fagers

Medical Centers

  • Respiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom,

  • StatMind AB, Lund, Sweden.

  • MRC/ARUK Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, United Kingdom

  • AstraZeneca, Molndal, Sweden

Locations

  • United Kingdom

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • Budesonide

  • Formoterol

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Parallel Group

Phase

  • NA

Study Id's

  • NCT00206167

  • NCT00206154

  • NCT00419744

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved